Iminosugars are an important class of natural products and have been subject to extensive studies in organic synthesis, bioorganic chemistry and medicinal chemistry, yet only a limited number of these studies are on glycosylated iminosugars. Here, a general route of synthesis is presented towards glycosylated 1-deoxynojirimycin derivatives based on the oxid-
Introduction
Iminosugars have received considerable interest in the past decades because of their potential to inhibit glycoprocessing enzymes. [1] A relatively unexplored class of iminosugars comprises the glycosylated deoxynojirimycin derivatives. Whereas monosaccharide iminosugars act as exoglycosidase inhibitors and sometimes also as glycosyl transferase inhibitors, iminosugars functionalized with a monosaccharide or an oligosaccharide may well act as inhibitors of another major class of glycoprocessing enzymes: endoglycosidases. Glycosylated iminosugars have been isolated from plants and microorganisms, often organisms that also produce 1-deoxynojirimycin (DNJ). [2] However, the natural abundance of such glycosylated iminosugars is often quite low, and the synthesis of glycosylated DNJ derivatives is therefore an attractive alternative. Three conceptual approaches can be discerned by means of which glycosylated DNJ have been prepared. These are 1) enzymatic glycosylation of DNJ derivatives; [3] 2) chemical glycosylation [4] of DNJ derivatives and 3) strategies [5] based on disaccharide (or oligosaccharide) entities as starting material. The enzymatic glycosylation of DNJ derivatives has been accomplished using glycohydrolases as catalysts in transglycosylation of an appropriate donor glycoside. One of the earliest endeavors in this vein comprises the synthesis of malto-DNJ using α-cyclodextrin as glucose donor and bacillus macerans amylase as transglyc-ation-reductive amination protocol that in the past has also been shown to be a versatile route towards 1-deoxynojirimycin. The strategy can be applied on commercial disaccharides, as shown in four examples, as well as on disaccharides that are not commercially available and are synthesized for this purpose, as shown by a fifth example.
osylase. [3a] Following these studies, it was shown that a variety of alternative glycosides including p-nitrophenyl-α-D-galactose, [3b] UDP-glucose, [3c] and lactose [3d] are effective donor glycosides as well, expanding the methodology to yield a variety of glycosylated DNJ derivatives. Enzymatic approaches hold several advantages, including mild reaction conditions, readily available starting materials and short reaction sequences. However, enzymatic synthesis also has its limitations, including structural diversity that can be obtained in general and, in particular in the use of transglycosylations, the potential formation of structural isomers. For example, when cellobiose was chosen as glycosyl donor and yeast -glucosidase as the transglycosylase catalyst, a mixture of glycosylated DNJs was obtained.
[3e]
Because of their similar chemical and physical properties, separation of such a mixture can be a challenge. Chemical glycosylation forms an attractive alternative for enzymatic glycosylation of DNJ. [4] In chemical glycosylation approaches, part of the hydroxyl groups in the acceptor (DNJ) are selectively protected, leaving the hydroxyl to be modified available for glycosylation using an appropriate donor and activation strategy. Since the synthesis of a donor and acceptor may take quite a few protection and deprotection steps, this strategy may be -compared to enzymatic synthesis -somewhat long and tedious. The third conceptual strategy towards glycosylated DNJ derivatives that has been studied to some extent comprises the use of disaccharides as starting material. [5] In this strategy multistep preparation of the donor and acceptor moieties is avoided, but the caveat is that appropriate disaccharide starting materials should be available. The transformation of disaccharides into glycosylated DNJ derivatives described in this work is rooted in the double reductive amination strategy earlier applied by us, [6] and others, [7] for the synthesis of DNJ. In this strategy, the anomeric center of a partially protected disaccharide is selectively exposed, and the hemi-acetal reduced to generate the key 1,5-diol intermediate. This diol is oxidized to the keto-aldehyde, which in a double reductive amination event is transformed into the target glycosylated DNJ derivative. An important feature of this Scheme is the recovery of the stereo-center at C5 of the newly formed iminosugar, which works well when the glucopyranose configuration is the desired one.
Results and Discussion
The synthesis of 6-O-(α-D-galactopyranosyl)-1-deoxynojirimycin (9, 1-deoxy-melibio-DNJ) is depicted in Scheme 1 and reveals the general strategy we also applied for the preparation of the ensuing aza-disaccharides (14, 19, 24 and 29, see Scheme 2, Scheme 3, Scheme 4 and Scheme 5, respectively). Scheme 1. Reagents and conditions: a) Ac 2 O, NaOAc, reflux, 90 %. b) PhSH, BF 3 ·OEt 2 , CH 2 Cl 2 , 82 %. c) 1) NaOMe, MeOH; 2) NaH, BnBr, DMF, 50 % over the two steps. d) NIS, TFA, CH 2 Cl 2 , 77 %. e) LiAlH 4 , THF, 74 %. f) oxalyl chloride, DMSO, Et 3 N, -78°C. g) HCO 2 NH 4 , Na 2 SO 4 , NaCNBH 3 , h) H 2 , Pd/C (10 %), DMF/ MeOH, HCl (aq), 50 % over the three steps.
Treatment of melibiose 1, which is commercially available, with sodium acetate in refluxing acetic anhydride afforded peracetylated melibiose 2, which was treated with thiophenol and BF 3 ·OEt 2 to give phenylthiomelibioside 3 in 74 % yield over the two steps. Zémplen deacetylation followed by benzylation yielded perbenzylated thiomelibiose 4, the thiophenyl group in which could be removed using conditions we developed previously [8] (treatment with N-iodosuccinimide and trifluoroacetic acid) to yield lactol 5 as the key intermediate in 39 % yield over the three steps. In the next step, the hemiacetal moiety in 5 was reduced (lithium aluminum hydride) to give diol 6, which was oxidized to keto-aldehyde 7 using Swern conditions. Double reductive amination with concomitant regeneration of the chiral center at C-5 (DNJ ring, glucopyranose numbering) was had the D-gluco-configuration (as in DNJ). The coupling constants between H-4 and H-5 (9.5 Hz) and between H-2 and H-3 (9.1 Hz) are in full agreement with the stereochemistry of 8, and the stereochemical outcome of the double reductive amination step is therefore as was observed previously for the synthesis of DNJ using the same sequence of events (reduction of the hemi-acetal in 2,3,4,6-tetra-O-benzyl-glucopyranose, followed by Swern oxidation of both primary and secondary alcohol and finally double reductive amination of the intermediate 5-keto-aldehyde [6c] ). Removal of the benzyl groups in 8 by palladium-catalyzed hydrogenation gave the target iminodisaccharide 9 in 11 % overall yield starting from 1.
The synthesis strategy applied for the assembly of 4-O-(α-D-glucopyranosyl)-1-deoxynojirimycin (14, 1-deoxy-malto-DNJ) was identical as described for the synthesis of 8, starting from maltose (10).
Lactol 12 was uneventfully obtained from maltose 10 in a yield of 47 % over the five steps. Lithium aluminum hydride reduction of 12 followed by Swern oxidation (12 to 13) of both primary and secondary alcohol and double reductive amination produced fully protected 1-deoxy-malto-DNJ (33 % yield, three steps). The stereochemical outcome in synthesizing 32 was again demonstrated by proton NMR spectroscopy (see the Experimental Section). The benzyl groups were removed by palladium-catalyzed hydrogenolysis to form target iminosugar 14 in 11 % overall yield starting from 10.
The synthesis of 4-O-( -D-galactopyranosyl)-1-deoxynojirimycin 19 (1-deoxy-lacto-DNJ) starts with lactose 15 (Scheme 3), which is one of the cheapest disaccharide known and is a side product of the dairy industry. Peracetylation of lactose 15 followed by generation of the thiolactoside, Zémplen removal of the acetates, benzyl protection and NIS/TFA thioglycoside hydrolysis as described before afforded lactol 17. In the next series of events, lactol 17 was reduced (lithium aluminum hydride), subjected to Swern oxidation (17 to 18) followed by a double reductive amination and treatment with palladium on carbon and dihydrogen gas to give the desired imino-disaccharide 19 in 14 % overall yield starting from 15.
Starting from cellobiose 20, 4-O-( -D-glucopyranosyl)-1-deoxynojirimycin 24 (1-deoxy-cellobio-DNJ) was obtained (Scheme 4) in 10 % overall yield following the sequence of events as described for the synthesis of 9 (1-deoxy-melobio-DNJ).
The examples described above (compounds 9, 14, 19 and 24, Scheme 1, Scheme 2, Scheme 3, and Scheme 4) comprise the use of cheap, readily available disaccharides featuring a glucopyranose moiety at the reducing end as starting material. Obviously, many disaccharides other than the ones used can be envisaged as starting material and that have a similar lay-out: a glycosylated glucopyranose. Besides making use of available disaccharides of this nature, one can also synthesize these by chemical glycosylation of a partially protected glucopyranose moiety, as is exemplified in Scheme 5.
is one of several glycosylated DNJ derivatives (including 1-deoxy-melobio-DNJ, 24) found both in mulberry trees (Morus alba L.) and silkworms (Bombyx mori L.) that feed on leaves from these trees, and is a moderately potent inhibitor of digestive glycosidases (maltase, sucrose) in rat.
[2c] In order to access compound 29 following the general procedure subject of this work, the appropriately protected disaccharide 28 is required, which on paper can be derived from 2-O-(α-D-galactopyranosyl)-glucose. In contrast to other disaccharides, however, this disaccharide is scarce and not commercially available, and thus the route of synthesis as outlined in Scheme 5 is followed.
Treatment of the donor monosaccharide, N-phenyl-trifluoromethyl galactose imidate 25 (prepared following the literature procedures, [10] see the Experimental Section) and the acceptor monosaccharide, thioglycopyranoside 26 (see for its preparation [11] the Experimental Section) with trimethylsilyl trifluoromethanesulfonate in dichloromethane at 0°C gave fully protected disaccharide 27 in 69 % yield and excellent α-stereoselectivity, as expected for glycosylations of 4-6-O-silylidene protected galactopyranose donors.
[12] Sequential removal of the silylidene protective group (treatment with tetrabutyl ammonium fluoride) and the benzylidene protective group (treatment with catalytic p-toluenesulfonic acid) followed by benzylation of the thus liberated four hydroxyl groups afforded fully benzylated phenylthiodisaccharide 28. This disaccharide was then transformed into Gal-DNJ 29 following the established sequence of events: thioacetal hydrolysis, hemiacetal reduction, oxidation of both primary and secondary alcohol, double reductive amination and final global debenzylation.
One interesting though not fully explained observation we made during our efforts to synthesize phenylthiodisaccharide 27 is that, when executing the glycosylation at -78°C, the reaction turned out to be unproductive. Instead of obtaining 27, no less than 70 % of α-phenylthiogalactoside 31 (Scheme 6) was obtained, with little to no formation of compound 27 observed. Elevating the reaction temperature appeared to favor formation of 27 over that of 31. At -20°C, the product ration of 27:31 was 35:30, and as described above, at 0°C compound 27 was obtained as the exclusive isolated compound in good yield.
Although we have no satisfactory explanation for the temperature dependence of this aglycon transfer (See Scheme 6), there is literature precedence [13] for this phenomenon. This undesirable aglycon transfer is generally circumvented by the use of bulky anomeric thiols or tuning of the protecting groups of the acceptor, but these approaches require new synthetic routes to the acceptor nucleophile. Although the reasons for the shift in reaction outcome as a function of the reaction temperature remain unclear at present it does represent a very effective means to circumvent the unproductive side reaction.
In conclusion, this work reports on the synthesis of five glycosylated 1-deoxynojimycin derivatives. Four of these, (24) were synthesized from their commercially available disaccharide (melibiose, maltose, cellobiose and lactose, respectively) as precursor. As a further example, 2-O-(α-galactopyranosyl)-1-deoxynojirimycin (Gal-DNJ, 29) was also successfully synthesized via the same methodology from its corresponding disaccharide, and the precursor disaccharide for this transformation was synthesized via chemical glycosylation. Thus the methodology presented appears general and, though yields vary between the individual synthesis schemes glycosylated DNJ derivatives can be prepared without difficulties from their glycosylated glucose counterparts, as long as the latter are synthetically tractable. One intrinsic shortcoming of the presented procedure is the temporarily destruction of the chiral center at C5 (glucopyranose numbering). Whereas recovery in the presented examples of this chiral center during reductive amination is excellent, such stereoselectivity may not occur when starting from differently configured reducing sugars. Thus the presented methodology will likely be less fruitful when targeting disaccharidic iminosugars featuring, say, a mannojirimycin or galactonojirimycin iminosugar. On the positive side, L-ido-configured iminosugar disaccharides should be within easy reach by bismesylation of the diol in, for instance, 6 (Scheme 1), followed by nucleophilic displacement of both mesylates with an amine. Such a strategy would again transpose a route of synthesis that has been proven [6b] to be versatile for the construction of non-glycosylated iminosugars to tailored starting materials yielding glycosylated ones. Another obvious extension would be to start, not from disaccharides, but rather from oligosaccharides (for instance, cello/malto oligosaccharides) and thus prepare larger oligosaccharides, the reducing end sugar of which is substituted for DNJ. When refluxing began the heat source was removed and melibiose (10.0 g, 29.2 mmol), which was co-evaporated with toluene (3 ×), was added in small portions. The mixture was heated to reflux for 1 hour. TLC analysis confirmed complete consumption of the starting material 1 (1:1, PE/EtOAc, R F = 0.39). The mixture was poured into ice water (400 mL) which was vigorously stirred. DCM (150 mL) was added and the layers were separated. The organic layer was washed with cold water (150 mL), sat. aq. NaHCO 3 solution (2 × 150 mL) and brine (150 mL) and the organic layer was dried (Na 2 SO 4 ), filtered, and concentrated. The residue was purified with silica gel column chromatography (2:1 → 1:1 → 1:2, PE/EtOAc) to give 2 in 90 % yield (17. 
2,3,4-Tri-O-acetyl-6-O-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)-1-thio-D-glucopyranose (3):
PhSH (5.2 mL, 51.0 mmol) was added to a stirred solution of 2 (17.8 g, 26.2 mmol) in dry DCM (50 mL) and kept under argon atmosphere. After cooling the solution to 0°C, BF 3 ·Et 2 O (4.9 mL, 39.7 mmol) was added dropwise, upon which the solution turned to orange. The mixture was stirred for 4 hours at room temperature, after which TLC analysis showed complete consumption of the starting material. DCM (50 mL) was added to the reaction mixture and the solution was washed with sat. aq. NaHCO 3 (100 mL, 2 ×). The organic layer was dried (Na 2 SO 4 ). After filtration, concentration and evaporation of the volatiles, the crude product was purified by silica gel column chromatography (3:1 → 7:3 → 1:1, PE/EtOAc), to give 3 as a white solid product in 82 % yield (15.6 g, 21.4 mmol). R F = 0.43 (1:1, PE/EtOAc). 1 
2,3,4-Tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-1-thio-D-glucopyranose (4):
Compound 3 (15.0 g, 20.6 mmol) was co-evaporated with toluene (3 ×) and dissolved in dry MeOH (100 mL). A catalytic amount of NaOMe was added and the reaction mixture was stirred for two hours. TLC-MS analysis showed complete conversion of the starting material into a more polar product. The mixture was diluted with MeOH after which Amberlite H + was added until the pH was adjusted to 7. After filtration and concentration the thus obtained product (D-galactopyranosyl-1-thio-D-glucopyranose) was co-evaporated with toluene (3 ×), dissolved in DMF (100 mL), and BnBr (20.9 mL, 176 mmol) was added. The solution was cooled to 0°C, and NaH (14.5 g, 360 mmol) was added in small portions, after which the solution was stirred overnight under argon atmosphere. TLC analysis showed complete consumption of the starting compound (1:1, PE/EtOAc). After cooling down to 0°C, the reaction mixture was quenched with MeOH, after which the volatiles were evaporated and EtOAc (200 mL) added. The mixture was washed with HCl solution (1 M, 100 mL, 2 ×). After being dried (Na 2 SO 4 ), filtered, and concentrated, the crude product was purified with silica gel column chromatography (17:3 → 4:1 → 1:1, PE/EtOAc) to give 4 in 50 % yield over the 2 steps (11. 
2,3,4-Tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-α/ -glucopyranose (5):
NIS (22 mg, 97 μmol) and TFA (30 μL, 0.39 μmol) were added to a cooled solution of 4 (94 mg, 88 μmol) in DCM (2 mL) at 0°C. After an hour of stirring TLC analysis (4:1, toluene/EtOAc) showed complete consumption of the starting material. Sat. aq. Na 2 S 2 O 3 (7 mL) followed by sat. aq. NaHCO 3 (7 mL) were added. The mixture was diluted with DCM, and after 30 minutes of stirring the layers were separated. The organic layer was dried (MgSO 4 ) and after filtering and concentrating the crude product was purified on silica gel column chromatography (9:1 → 7:3 → 6:4, PE/EtOAc) to give 5 in 77 % yield (70 mg, 68 μmol). R F = 0.30 and 0.40 (7:3, PE/EtOAc). For the major anomer: 1 
2,3,4-Tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-D-glucitol (6):
LiAlH 4 in THF (6.0 mL, 2 M, 12.0 mmol) was slowly added to a cooled (0°C) solution of 5 (3.91 g, 4.02 mmol, co-evaporated 3 × with toluene), in dry THF (40 mL) under argon atmosphere. The mixture was stirred overnight allowing the temperature to reach room temperature TLC analysis showed absent of the starting compound (7:3, PE/EtOAc). The mixture was cooled in an ice-bath, after which it was slowly quenched with H 2 O. Then NaOH solution (3 M, 40 mL) was added followed by celite. The solution was stirred until a homogeneous mixture was formed after which it was filtered and the filter cake rinsed with Et 2 O. H 2 O (50 mL) and EtOAc (50 mL) was added and the organic layer was dried (Na 2 SO 4 ), filtered and concentrated, after which the residue was purified by silica gel column chromatography (4:1 → 7:3 → 3:2, PE/EtOAc) to give 6 as a yellow oil in 74 % yield (2.88 g, 2.95 mmol). R F = 0.22 (7:3, PE/EtOAc). 
2,3,4-Tri-O-benzyl-6-O-(2,3,4,6-tetra-α-D-galactopyranosyl)-1-deoxynojirimycin (8):
A solution of (COCl) 2 (1.2 mL, 14.0 mmol) in dry DCM (15 mL) under argon atmosphere, was cooled to -78°C. DMSO (1.2 mL, 16.9 mmol) dissolved in dry DCM (12 mL) was added dropwise. After 40 min, 7 (4.28 g, 3.22 mmol, co-evaporated 3 × with toluene), in dry DCM (18 mL), was added dropwise to the mixture. The reaction was stirred for 2 h at -70°C, after which Et 3 N (5.4 mL, 38.7 mmol) was added dropwise. The mixture was gradually warmed to -5°C after which it was poured into a cooled (0°C) MeOH solution (200 mL) containing NaCNBH 3 (0.81 g, 12.3 mmol), HCOONH 4 (4.07 g, 64.5 mmol), and Na 2 SO 4 (1.37 g, 9.67 mmol). The mixture was stirred overnight allowing the reaction to reach room temperature. TLC analysis showed the formation of the product. After filtering, the solvents were evaporated, after which the residue was dissolved in EtOAc (200 mL). 
6-O-(α-D-Galactopyranosyl)-1-deoxynojirimycin (9):
A mixture of DMF/MeOH (1:1, 20 mL), HCl (2 mL, 1 M) and 8 (2.00 g, 2.09 mmol) was flushed with argon (3 ×). Then a catalytic amount of Pd/C (20 %) was added, after which H 2 was flushed through the mixture, letting the solution shake overnight under H 2 atmosphere (4 bar). HPLC analysis showed complete conversion of starting material into desired product. Then the catalyst was filtered and the solution was concentrated. The crude product was purified on size-exclusion column (NH 4 HCO 3 in water 0.15 M). After co-evaporating (3 ×) with MilliQ water, product 9 was obtained as a white solid in 75 % yield (326 mg, 1.00 mmol). When refluxing began the heat source was removed and maltose (9.94 g, 29.0 mmol, co-evaporated with 3 × toluene) was added in small portions. The mixture was heated again to reflux and after an hour, TLC analysis confirmed the formation of the product (1:1, PE/ EtOAc, R F = 0.36). The mixture was poured into ice water (400 mL) and vigorously stirred. DCM (150 mL) was added and the layers were separated after which the organic layer was washed with water (200 mL), sat. aq. NaHCO 3 solution (2 × 150 mL) and brine (200 mL). After the organic layer was dried (Na 2 SO 4 ), filtered, and concentrated, the residue was purified by silica gel column chromatography (1:1 → 1:2 → 0:1, PE/EtOAc) to give pure 11 in 94 % yield (18.5 g, 27.3 mmol). 2,3,6-Tri-O-benzyl-4-O-(2,3,4,6-tetra-O-benzyl-α-D- 
4-O-(α-D-Glucopyranosyl)-1-deoxynojirimycin (14):
Step 1: According to the procedure described for the preparation for compound 6, 2, 13 Step 2: According to the procedure described for the preparation for compound 8, 
2,3,6-Tri-O-benzyl-4-(2′,3′,4′,6′-tetra-O-benzyl--D-galactopyranosyl)-α/ -D-glucopyranose (17):
Step 1: According to the procedure described for the preparation for compound 4, 2,3,6-tri-Obenzyl-4-(2′,3′,4′,6′-tetra-O-benzyl--D-galactopyranosyl)- 
4-( -D-Galactopyranosyl)-1-deoxynojirimycin (19):
Step 1: According to the procedure described for the preparation for com- 
2,3,6-Tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl--D-glucopyranosyl)-1-thio-D-glucopyranose (21):

4-O-( -D-Glucopyranosyl)-1-deoxynojirimycin (24):
Phenyl-3-O-benzyl-4,6-O-benzylidene-1-thio--D-glucopyranoside (26):
The glucose acceptor was prepared following the literature procedures. [ 1 1 ] Step 1: -D-Glucose penta-acetate (1.00 g, 2.56 mmol) and PhSH (0.4 mL, 4 mmol) were dissolved in DCM (20 mL). The mixture was cooled to 0°C and BF 3 ·Et 2 O (0.46 mL, 3.7 mmol) was added dropwise. After 5 hours, TLC analysis showed complete consumption of the starting compound. The mixture was washed with sat. aq. NaHCO 3 , organic layer was dried (Na 2 SO 4 ), filtered and concentrated. The crude product was purified with silica gel column chromatography to gain the phenyl-1-thio-2,3,4,6-tetra-(O-acetyl)--D-glucopyranoside as white crystals (1.02 g, 2.33 mmol, yield 91 %). R F = 0.7 (5:3, PE/EtOAc). 33 mmol) in toluene (17 mL), the reaction mixture was stirred overnight at 115°C. Then toluene was evaporated, the residue was dissolved in DMF (10 mL), and CsF (0.31 g, 2.04 mmol), BnBr (0.3 mL, 2.5 mmol) was added. The reaction mixture was stirred at 115°C for 12 hours. After TLC analysis showed complete consumption, the reaction mixture was diluted with EtOAc, washed successively with NaHCO 3 solution and brine. The organic layer was dried (Na 2 SO 4 ), concentrated and the residue was purified with a short column ( Step 2: Phenyl-1-thio--D-galactopyranoside was synthesized from the phenyl-1-thio-2,3,4,6-tetra-O-acetyl--D-galactopyranoside (59.00 g, 133.95 mmol), using thiophenol (0.4 mL, 3.91 mmol) and BF 3 ·Et 2 O (0.46 mL, 3.72 mmol) according to the procedure described for the deprotection of the phenyl-1-thio--D-glucopyranoside. The crude product was used in next step without further purification. The crude thiogalactopyranoside (3.12 g, 11.5 mmol) was co-evaporated with DMF. The mixture was dissolved in pyridine (20 mL). The solution was cooled to -20°C and tBuSi(OTf) 2 (3.5 mL, 9.9 mmol) was added. After 2 hours, TLC analysis showed complete consumption of the starting compound. MeOH was added to quench the reaction. The solution was concentrated and diluted with EtOAc, washed with HCl (1 M) and sat. aq. NaHCO 3 . The organic layer was dried (Na 2 SO 4 ), filtered and concentrated. The residue was purified with silica gel column chromatography (1:4 → 1:3, EtOAc/PE) to gain the 4,6-O-di-tert-butylsilylene thiogalactopyranoside (2.49 g, 6.04 mmol, yield 53 %) as light yellow oil. R F = 0.34 (1:1, PE/EtOAc). 1 , 1 H, H-3), 3.81 (br-s, 1 H, H-5 ), 1.10 (s, 9 H, 3 × CH 3 ), 1.02 (s, 9 H, 3 × CH 3 ). 13 
